2020
DOI: 10.1016/j.dib.2020.106352
|View full text |Cite
|
Sign up to set email alerts
|

Draft genome sequence data of Erysipelothrix rhusiopathiae vaccine strain VR-2

Abstract: Data on the draft genome sequence of Erysipelothrix rhusiopathiae strain VR-2 is presented in this report. E. rhusiopathiae strain VR-2 is a commercial attenuated vaccine widely used in Russia and a number European countries for immunization of pigs against swine erysipelas. The draft genome sequence of 1,704,727 bp in length included 1415 protein sequences, 50 tRNA genes and 3 rRNA genes according NCBI Prokaryotic Geno… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…The phylogenetic inference of 27 E. rhusiopathiae strains was performed on a 1210-coregene super-alignment identified using Roary v3.13.0. Strains 1023, 1012, and 267 formed a separate clade, differing in ~226-1070 SNPs, while strain 584 was located in a different part of the dendrogram and showed high relatedness to strain VR-2 isolated from a pig in Russia [49] (Figure 5). The results of the analysis indicate that the tested E. rhusiopathiae strains belong to two clonal lineages.…”
Section: Phylogenetic Inferencementioning
confidence: 99%
“…The phylogenetic inference of 27 E. rhusiopathiae strains was performed on a 1210-coregene super-alignment identified using Roary v3.13.0. Strains 1023, 1012, and 267 formed a separate clade, differing in ~226-1070 SNPs, while strain 584 was located in a different part of the dendrogram and showed high relatedness to strain VR-2 isolated from a pig in Russia [49] (Figure 5). The results of the analysis indicate that the tested E. rhusiopathiae strains belong to two clonal lineages.…”
Section: Phylogenetic Inferencementioning
confidence: 99%